Medios DR
*The product is not available for sale in the US
Helps you detect Diabetic Retinopathy lesions in less than 10 seconds, offline.
Helps you detect Diabetic Retinopathy lesions in less than 10 seconds, offline.
Helps you detect Diabetic Retinopathy lesions in less than 10 seconds, offline.
Medios DR scans fundus images for referable diabetic retinopathy (RDR) . Medios AI eliminates the need for a specialist in the early stage of DR.
Medios works offline, making it a perfect choice for use in areas with no network access. Provides quick exam results and, in the end, generates a detailed report with lesion areas highlighted.
Medios is clinically validated for 92.5% specificity and 93% sensitivity in multiple studies
Medios DR can be an integrated part of the Fundus on Phone. It scans fundus images for referable diabetic retinopathy (DR) . Medios AI eliminates the need for a specialist in the early stage of DR.
Medios works offline, making it a perfect choice for use in areas with low network coverage.
MediosDR is clinically validated for 99% specificity and 99% sensitivity in multiple studies
At the end of the test, a detailed report is generated. Lesion areas are highlighted.
A variety of in-app settings allow you to optimise the image to your liking. Whether your slit lamp uses LED or halogen based lighting, you can adjust the image to match the source.
“It has been a very good experience interacting the device and customer support offered by your sales & service teams. We are happy to recommend this product to our fellow doctors. Remidio’s products are a good fit to have in terms of operations, cost. Keep up the good work with innovative products.”
“I am very happy with the performance of Fundus on Phone Device. The prices were affordable and the device is handy in terms of portability. The device is very helpful in patient education for retina & uveitis cases. “
If you have questions about the product or want to see a live demonstration, please let us know
Contact Us